The Journal of Cancer Biology, Therapeutics and Clinical Oncology aims to serve as a comprehensive and authoritative platform for the dissemination of high-quality research in the field of cancer science and treatment. The journal is devoted to advancing the understanding of cancer at the molecular, cellular, and clinical levels, while also fostering innovation in therapeutic strategies and diagnostic approaches. By encouraging interdisciplinary collaborations and translational research, the journal seeks to contribute to improved outcomes in cancer care and support the evolving landscape of oncology.

Scope of the Journal

The journal welcomes original research and scholarly articles that explore a broad spectrum of topics within cancer biology and oncology. Contributions may range from laboratory-based investigations of carcinogenesis to clinical evaluations of emerging therapies. Areas of interest include, but are not limited to:

• Molecular and cellular mechanisms of cancer development
• Tumor initiation, progression, and metastasis
• Genetic and epigenetic regulation in cancer
• Cancer immunology and tumor microenvironment
• Identification and validation of cancer biomarkers
• Signal transduction pathways in cancer
• Cancer genomics, proteomics, and metabolomics
• Cancer stem cells and resistance mechanisms
• Precision oncology and targeted therapy
• Anticancer drug discovery and development
• Chemotherapy, radiotherapy, and immunotherapy
• Hormonal and biological therapies
• Combination therapy strategies
• Clinical trials and therapeutic efficacy studies
• Diagnostic imaging and early cancer detection
• Surgical oncology and interventional techniques
• Supportive care and symptom management in oncology
• Personalized medicine and pharmacogenomics
• Epidemiology, prevention, and cancer risk factors
• Pediatric, geriatric, and rare cancer research
• Quality of life, survivorship, and palliative care
• Health disparities and global oncology challenges
• AI and computational tools in cancer research
• Cancer education and healthcare delivery innovations

Translational and Interdisciplinary Research

A key focus of the journal is on translational research that bridges the gap between bench and bedside. Manuscripts that connect laboratory findings to clinical applications—such as those investigating the therapeutic relevance of molecular pathways or evaluating new drug candidates in preclinical models—are highly encouraged. In addition, the journal supports interdisciplinary research that integrates fields such as nanomedicine, systems biology, bioinformatics, pharmacology, and biomedical engineering with cancer research.

Clinical Oncology and Therapeutic Advances

The journal is particularly interested in publishing work that addresses clinical oncology, including diagnostic procedures, therapeutic protocols, and patient-centered care. Studies reporting on novel therapeutic approaches, efficacy comparisons between existing treatment options, and real-world evidence from clinical practice are welcome. Submissions highlighting improvements in radiation oncology, surgical interventions, combination regimens, and immunotherapeutic techniques are of special relevance.

Emerging Technologies and Innovation

Recognizing the rapid evolution of cancer diagnostics and therapeutics, the journal seeks to highlight research incorporating emerging technologies. Manuscripts involving artificial intelligence applications in oncology, machine learning for predictive modeling, nanotechnology for targeted drug delivery, and digital pathology tools are considered within scope. The journal encourages forward-looking studies that demonstrate potential for real-world clinical translation.

Global Perspectives and Inclusive Research

To support inclusive and equitable research, the Journal of Cancer Biology, Therapeutics and Clinical Oncology invites contributions from diverse geographic and economic settings. Studies that address region-specific cancer burdens, local treatment challenges, and population-based epidemiological insights are especially welcome. The journal promotes global participation and values submissions that offer contextually relevant data applicable to low- and middle-income countries as well as underrepresented populations.

Article Types Accepted

The journal accepts a wide range of article types, including:

• Original Research Articles
• Review Articles
• Systematic Reviews and Meta-Analyses
• Case Reports and Case Series
• Short Communications
• Clinical Perspectives
• Editorials and Commentaries
• Technical Notes and Methodological Papers

Authors are encouraged to consult the journal’s submission guidelines to ensure proper formatting and compliance with ethical standards prior to manuscript submission.

Audience and Readership

The Journal of Cancer Biology, Therapeutics and Clinical Oncology is intended for a global audience of researchers, clinicians, oncologists, biomedical scientists, academic professionals, and public health experts involved in cancer research and patient care. The journal aims to support both academic inquiry and practical implementation by presenting data that informs clinical decisions, influences policy, and stimulates innovation in therapeutic development.

Commitment to Open Science

As an open-access journal, all content published is made freely available without subscription barriers. This model ensures the widest possible dissemination of research findings and facilitates the exchange of ideas across borders and disciplines. The journal is committed to fostering a collaborative academic environment where new discoveries can be rapidly shared and effectively utilized to advance cancer research and treatment worldwide.

Conclusion

By embracing a broad and inclusive scope, the Journal of Cancer Biology, Therapeutics and Clinical Oncology aims to reflect the multifaceted nature of cancer research today. The journal provides a home for both foundational biological studies and applied clinical research, offering a platform where innovation, scientific rigor, and translational impact converge. Authors whose work contributes to the understanding, prevention, diagnosis, or treatment of cancer are invited to submit their manuscripts and become part of this important dialogue.